NCM

Nantahala Capital Management Portfolio holdings

AUM $1.68B
1-Year Est. Return 115.06%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+115.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$206M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
167
New
Increased
Reduced
Closed

Top Buys

1
+$17.3M
2
+$15.7M
3
+$12M
4
EOLS icon
Evolus
EOLS
+$11.9M
5
LBRX
LB Pharmaceuticals
LBRX
+$10.7M

Top Sells

1
+$56.7M
2
+$19M
3
+$18.8M
4
THRD
Third Harmonic Bio
THRD
+$16M
5
GOGO icon
Gogo Inc
GOGO
+$15.3M

Sector Composition

1 Healthcare 69.32%
2 Consumer Discretionary 12.89%
3 Financials 5.23%
4 Communication Services 4.07%
5 Industrials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHX icon
76
DHI Group
DHX
$122M
$6.6M 0.41%
2,374,027
CMCO icon
77
Columbus McKinnon
CMCO
$456M
$6.45M 0.4%
450,000
+246,372
VMD icon
78
Viemed Healthcare
VMD
$365M
$6.33M 0.39%
932,445
STKS icon
79
The ONE Group
STKS
$54.9M
$6.28M 0.39%
2,121,084
MLYS icon
80
Mineralys Therapeutics
MLYS
$2.35B
$6.02M 0.37%
158,713
-195,269
DXLG icon
81
Destination XL Group
DXLG
$39.4M
$5.9M 0.36%
4,505,000
+1,928,226
IRD
82
Opus Genetics
IRD
$372M
$5.52M 0.34%
3,345,923
AKBA icon
83
Akebia Therapeutics
AKBA
$383M
$5.46M 0.34%
2,000,000
GAIA icon
84
Gaia
GAIA
$74.9M
$5.41M 0.33%
914,618
SLN
85
Silence Therapeutics
SLN
$370M
$5.41M 0.33%
1,042,427
NNBR icon
86
NN Inc
NNBR
$131M
$5.03M 0.31%
2,441,416
QNCX icon
87
Quince Therapeutics
QNCX
$22.2M
$5.01M 0.31%
307,373
+54,543
SCPH
88
DELISTED
scPharmaceuticals
SCPH
$4.88M 0.3%
861,277
-134,161
KOD icon
89
Kodiak Sciences
KOD
$2.81B
$4.76M 0.29%
290,884
-300,000
HAIN icon
90
Hain Celestial
HAIN
$77.9M
$4.74M 0.29%
3,000,000
CGON icon
91
CG Oncology
CGON
$5.9B
$4.41M 0.27%
+109,449
BRCC icon
92
BRC Inc
BRCC
$129M
$4.1M 0.25%
+2,630,517
UNCY icon
93
Unicycive Therapeutics
UNCY
$185M
$4.09M 0.25%
939,202
AGIO icon
94
Agios Pharmaceuticals
AGIO
$1.51B
$4.01M 0.25%
+100,000
RYAM icon
95
Rayonier Advanced Materials
RYAM
$657M
$3.69M 0.23%
+510,510
IKT icon
96
Inhibikase Therapeutics
IKT
$255M
$3.55M 0.22%
2,190,000
GRCE
97
Grace Therapeutics
GRCE
$36.4M
$3.51M 0.22%
1,178,203
AQST icon
98
Aquestive Therapeutics
AQST
$497M
$3.35M 0.21%
+600,000
TLPH icon
99
Talphera
TLPH
$40M
$3.12M 0.19%
3,492,519
+1,500,000
NPCE icon
100
Neuropace
NPCE
$573M
$3.04M 0.19%
295,089
2 3
4
5 6